Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer (Q40183984)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 February 2007
edit
Language Label Description Also known as
English
Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer
scientific article published on 7 February 2007

    Statements

    Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer (English)
    David Masiello
    M Golam Mohi
    Nicole C McKnight
    Bradley Smith
    Ben G Neel
    Steven P Balk
    Glenn J Bubley
    7 February 2007
    195-201

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit